Skip to main content

Beckman Coulter to Evaluate Eksigent s Microfluidics Technology

NEW YORK, July 20 – Eksigent Technologies said Friday it had signed a deal with Beckman Coulter to jointly look for ways to incorporate Eksigent’s microfluidics technology into Beckman Coulter’s instruments.

Financial terms of the deal were not disclosed.

Established in May of last year, Eksigent of Livermore, Calif., has developed lab-on-a-chip technology, including pumps, valves, and microfabricated systems. The basis of the technology is the electrokinetic pump, which uses an applied electric field to generate fluid flow and high pressures. 

The company said that its pump can be applied to combinatorial chemistry, sample preparation, heat transfer, microvalving, and actuation.

“We anticipate that Eksigent's technology will enable the development of new instrumentation platforms that provide significant advantages to Beckman Coulter's customers,” Jim Osborne, vice president of Advanced Technology at Beckman Coulter, said in a statement.

Beckman Coulter of Fullerton, Calif., develops instruments and products that help to automate simplify laboratory processes. The company also develops diagnostics.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.